02Dec
UK Life Sciences and Healthcare Newsletter - December 2020: The UK National Security and Investment Bill
The UK has announced a bill proposing a new system to screen transactions for national security risk, separate from the system of merger review operated by the Competition and Markets Authority. The National Security and Investment Bill has been in the pipeline since the publication of the National Security Risk Assessment in 2015, but has been delayed due to Brexit and the COVID-19 pandemic....
By:
Dechert LLP
Related
This White Paper highlights some recent developments in certain countries relating to employee stock...
Read More >
ERISA requires disclosure of certain plan documents to participants including a summary plan descrip...
Read More >
Virtual Due Diligence Capabilities - As a general matter, the parties in an M&A transaction need to...
Read More >
The COVID-19 pandemic and the corresponding economic volatility has dramatically impacted the US and...
Read More >
First Circuit: Two affiliated funds did not form an implied partnership liable for pension obligatio...
Read More >
On April 22, 2020, the UK Competition and Markets Authority published guidance on its approach to me...
Read More >